...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Halted

this on TD 

 

ZHCLF

ZENITH CAP CORP
Trading halted
Share
New Message
Please login to post a reply